What is the new CF drug 2025? Introducing Alyftrek, the Next-Generation Treatment
•
4 min read
In a major advancement for cystic fibrosis (CF) care, the FDA approved Alyftrek in late 2024, and it became widely available in 2025, offering a significant upgrade for eligible patients. The question on many minds is, **what is the new CF drug 2025?** This once-daily triple-combination therapy simplifies treatment and continues the trend of targeted therapies that address the underlying cause of the disease.
